No Data
No Data
No Data
No Data
No Data
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise
Amneal Pharmaceuticals (AMRX) rallied Wednesday after the US Food and Drug Administration approved its generic version of the nasal spray used to treat opioid overdose. Amneal's Naloxone HCI nasal spr
MT Newswires15:25 ET
FDA Approves Amneal's Generic Version of OTC Narcan
Seeking AlphaApr 24 11:01 ET
Express News | Amneal Pharmaceuticals Shares Are Trading Higher After the Company Announced FDA Approval of OTC Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opiod Overdose
Moomoo 24/7Apr 24 08:58 ET
Express News | Amneal Announces FDA Approval Of Over-The-Counter Naloxone Hydrochloride Nasal Spray For Emergency Treatment Of Opioid Overdose
Moomoo 24/7Apr 24 08:12 ET
Express News | Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Moomoo 24/7Apr 24 08:00 ET
Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US
Shilpa Medicare's (NSE:SHILPAMED, BOM:530549) marketing partner Amneal Pharmaceuticals launched Pemrydi RTU, which is touted as the first ready-to-use pemetrexed formulation in the US, according to an
MT NewswiresApr 18 01:22 ET
No Data
No Data